Immunex Corporation

Type: Company
Name: Immunex Corporation
Nationality: United States
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Sangamo BioSciences Appoints H. Stewart Parker to its Board of Directors

By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the appointment of H. Stewart Parker to the Company's Board of Directors. Ms. Parker, who founded and served as President and CEO of Targeted ... [Published HispanicBusiness.com - Jun 26 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Anthony E. Namen, 70

, after a lengthy battle with multiple myeloma.Tony joined his big brother Jim in the Anthony and Kathryn Namen household on Aug. 3, 1943. “Uncle Tone” attended and graduated from Flathead County High School and Montana State University. Tony proudly ... [Published Daily Inter Lake - Jun 25 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Sangamo BioSciences appoints H. Stewart Parker to its board of directors

Sangamo BioSciences announced the appointment of H. Stewart Parker to the company's board of directors. Parker, who founded and was president and CEO of Targeted Genetics , brings more than 30 years of experience in the biotechnology industry, including ... [Published Center Watch - Jun 20 2014]
First reported Jun 19 2014 - Updated Jun 20 2014 - 2 reports

Sangamo BioSciences hires H Stewart Parker to board

Engineering genetic cures company Sangamo BioSciences (NasdaqGS:SGMO) revealed on Thursday the addition of H Stewart Parker to its board of directors. The company added that Parker was the founder, president and CEO of Targeted Genetics.Recently, Parker ... [Published Individual.com - Jun 20 2014]
First reported Jun 16 2014 - Updated Jun 16 2014 - 1 reports

Cultivating Biosimilars

With all the hoopla surrounding the passage of the Patient Protection and Affordable Care Act on March 23, 2010, relatively little notice was given to a piece of the legislation called the Biologics Price Competition and Innovation (BPCI) Act.The BPCI ... [Published Pharmaceutical Manufacturing Magazine - Jun 16 2014]
Entities: Biology, Victor Fung, Drugs
First reported Jun 04 2014 - Updated Jun 05 2014 - 1 reports

Ironwood Pharmaceuticals Appoints Douglas Williams, Ph.D., to Board of Directors

IronwoodPharmaceuticals, Inc. ( NASDAQ: IRWD ) announced today the appointmentof Douglas Williams, Ph.D., to its board of directors. Dr. Williamscurrently serves as executive vice president, research and developmentfor Biogen Idec Inc. and was previously ... [Published Market Pulse Navigator - Jun 04 2014]
First reported May 14 2014 - Updated May 14 2014 - 1 reports

Stem cell research advocate to speak at Pregnancy Care Clinic banquet

Theresa Deisher will speak at the Pregnancy Care Clinic dessert banquet.— image credit: Contributed photoThe Pregnancy Care Clinic will have a dessert banquet this weekend and host an expert credited with discovering adult cardiac-derived stem cells.Theresa ... [Published South Whidbey Record - May 14 2014]
First reported Apr 27 2014 - Updated Apr 27 2014 - 1 reports

Ultragreen building is ready for challenge | Sunday Buzz

Denis Hayes, guiding spirit of the supergreen Bullitt Center office building on Capitol Hill, is pleased to report that in its first year the six-story structure has yielded some unanticipated benefits: Since using what he calls the “irresistible stairway” ... [Published Seattle Times - Apr 27 2014]
First reported Mar 16 2014 - Updated Mar 16 2014 - 1 reports

Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof

The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in ... [Published PharmCast - Mar 16 2014]
First reported Feb 26 2014 - Updated Feb 26 2014 - 1 reports

Catalent Announces Two Senior Appointments to Expand Biologics Business

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced two senior appointments to further strengthen its global biologics business. ... [Published PRWeb - Feb 26 2014]

Quotes

...to bring Stewart onto our Board during such an important stage in Sangamo's development," said Edward Lanphier , Sangamo's president and CEO. "As we expand our manufacturing capabilities and advance ZFP Therapeutic(®) programs for the development of genetic cures for monogenic diseases, Stewart's proven entrepreneurial and executive leadership skills and extensive experience in AAV gene therapy, particularly cGMP manufacturing and clinical development, will be very valuable to Sangamo."
...Lastly, the procedure involves exercises to restore strength and coordination. "By pretreating a client with (Enbrel), we vastly speed up the entire process and obtain results that would not be possible without the Enbrel" stated Phillip Koss a ATQDA certified motor skills specialist...

More Content

All (16) | News (15) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Sangamo BioSciences Appoints H. Stewart Parker ... [Published HispanicBusiness.com - Jun 26 2014]
Anthony E. Namen, 70 [Published Daily Inter Lake - Jun 25 2014]
Sangamo BioSciences appoints H. Stewart Parker ... [Published Center Watch - Jun 20 2014]
Sangamo BioSciences hires H Stewart Parker to b... [Published Individual.com - Jun 20 2014]
Sangamo BioSciences Appoints H. Stewart Parker ... [Published Michigan Live - Jun 19 2014]
Cultivating Biosimilars [Published Pharmaceutical Manufacturing Magazine - Jun 16 2014]
Ironwood Pharmaceuticals Appoints Douglas Willi... [Published Market Pulse Navigator - Jun 04 2014]
Stem cell research advocate to speak at Pregnan... [Published South Whidbey Record - May 14 2014]
Ultragreen building is ready for challenge | Su... [Published Seattle Times - Apr 27 2014]
Cloned transmembrane receptor for 24-hydroxylat... [Published PharmCast - Mar 16 2014]
Catalent Announces Two Senior Appointments to E... [Published PRWeb - Feb 26 2014]
2013: The year's biggest Pharmaceutical Technol... [Published Pharmaceutical Technology - Jan 08 2014]
Cell-permeabilising peptides and polypeptides f... [Published PharmCast - Dec 01 2013]
New Stroke Treatment Enables People Who Have Be... [Published PRWeb - Oct 23 2013]
Strechforlife and Neurological Wellness Center ... [Published PRWeb - Sep 25 2013]
Amgen planning to buy Onyx for about $10.4 billion [Published Topnews.in - Aug 26 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.